COVID-19の影響を受けた消化器ステント市場：製品（胆道ステント、十二指腸ステント、大腸ステント、膵臓ステント、食道ステント）、材料（自己拡張型金属ステント、プラスチックステント）、用途、エンドユーザー別 - 2026年までの予測

Gastrointestinal Stent Market with COVID-19 Impact by Product (biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents), Material (self-expanding metal stents and plastic stents), Application, End User - Forecast to 2026

消化器用ステント市場は、2021年の4億5,700万米ドルから2026年には6億米ドルに達し、2021年から2026年の予測期間中に5.6％のCAGRで推移すると予測されています。消化管（GI）ステントは、GI管に閉塞を引き起こ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年2月11日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	216	247	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

消化器用ステント市場は、2021年の4億5,700万米ドルから2026年には6億米ドルに達し、2021年から2026年の予測期間中に5.6％のCAGRで推移すると予測されています。
消化管（GI）ステントは、GI管に閉塞を引き起こすさまざまな疾患の緩和療法用に設計されています。GIステントは、消化管（GI）腫瘍の再疎通や術後のリークシールに大きな役割を担っています。GIステントのその他の潜在的用途としては、薬剤溶出装置、良性疾患のための組織モデリング、GI管ドレナージ／吻合などが挙げられます。消化管ステント市場の成長は、GI癌やその他の消化器系疾患の有病率の上昇、ライフスタイルの変化、消化器系処置に対する医療支出の増加、低侵襲手術への嗜好の高まりに起因していると考えられます。

"胆道用ステントは最大の製品セグメント、食道用ステントは2020年に市場で最も急成長する消化管用ステントセグメント"
2020年のシェアは、胆道ステント部門が最も大きい。食道ステントセグメントは、予測期間中に最も高いCAGRで成長すると推定される。胆管癌と慢性肝疾患の有病率の増加は、胆道ステントセグメントの成長をもたらす顕著な要因の1つである。また、胆道疾患の発生率の増加や胆道疾患治療のための外科手術数の増加も、予測期間中にこの市場セグメントの成長をサポートすると予想される主な要因の1つです。米国がん協会の統計によると、2021年には米国で肝内胆管がんおよび原発性肝がんの新規症例が42,230件以上診断される可能性があります。このような要因に加え、米国では胆石などの消化器疾患が深刻に懸念されていることも、胆道閉塞の治療のために胆管ステントを留置する要因になり得ると考えられます。
"自己拡張型メタルステントセグメントが消化管ステント市場を支配する"
2020年、世界の消化器用ステント市場において、自己拡張型金属ステントセグメントが最大のシェアを占めています。これらのステントに対する需要の増加は、挿入の容易さ、脱落や移動の可能性の低さ、大きな内径による長い開存性、高い寿命、さまざまな悪性閉塞に対するインターベンション内視鏡での大きな使用などに起因していると考えられる。自己拡張型金属製ステントは、さらにニチノール製、ステンレス製、その他の金属製に細分化されます。
"消化管ステントの世界市場で最も速い成長を記録するのは消化管癌セグメント"
消化管ステント市場は、用途別に胆道疾患、過敏性腸症候群、消化管がんに分類されます。消化器がんはさらに、大腸がん、胃がん、食道がん、膵臓がんに分類されます。2020年には胆道系疾患セグメントが最大のシェアを占めた。消化器がんセグメントは、予測期間中に最も高いCAGRを示すと予測されます。このセグメントの成長は、消化器癌の有病率および発生率の増加に起因しています。例えば、米国がん協会の報告書「Colorectal Cancer Facts & Figures 2020-2022」によると、2020年、米国で新たに診断された結腸がんは104,610例、直腸がんは43,340例と推定されます。

"2020年の消化管ステント市場において、病院・クリニックが最大のエンドユーザーセグメント"
エンドユーザーに基づいて、消化管ステント市場は病院とクリニック、外来外科センターに区分されます。2020年には、病院・診療所セグメントが最大のシェアを占めています。このセグメントの大きなシェアは、異なる疾患の適応症のために病院で行われる内視鏡的逆行性胆管膵管造影（ERCP）および経皮経肝胆管造影（PTC）処置の数が多いこと、有利な償還シナリオ、消化器疾患に対する質の高い治療提供に対する政府の取り組みが増加していることに起因している可能性があります。
"2026年も北米が消化器ステント市場を支配する"
消化器用ステント市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの5つの主要地域に区分されます。2020年では、北米が最大のシェアを占めています。世界市場における北米の大きなシェアは、老年人口の増加、消化器疾患の高い発生率、有利な償還シナリオ、主要な市場プレイヤーの存在に起因しています。この市場の主要プレイヤーには、Boston Scientific Corporation（米国）、C.R. Bard（米国）、Becton, Dickinson and Company（米国）、Merit Medical Systems（米国）、CONMED Corporation（米国）、Cook Medical（米国）、Cantel Medical（米国）、Hobbs Medical（米国）などが含まれます。

主な参加企業の内訳は以下の通りです。
- 企業タイプ別：Tier1 45％、Tier2 30％、Tier3 25
- 役職別 - Cレベル：20％、ディレクターレベル：60％、その他：20
- 地域別：北米35％、欧州30％、アジア太平洋地域20％、中南米10％、中東・アフリカ5

調査対象。
当レポートでは、消化管ステント市場を分析し、製品、材料、用途、エンドユーザー、地域に基づく様々な市場セグメントの市場規模および今後の成長可能性を推定することを目的としています。また、同市場で事業を展開する主要企業の競争力分析を、企業プロファイル、製品提供、最近の開発、主要な市場戦略とともに掲載しています。
レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができるようになり、ひいては市場でのシェアを拡大するのに役立つことでしょう。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場でのポジションを強化することが可能です。
本レポートでは、以下に関する洞察を提供しています。
市場浸透度。胃腸用ステント市場におけるトッププレイヤーの製品ポートフォリオに関する包括的な情報。製品、材料、アプリケーション、エンドユーザー、地域別に市場を分析します。
市場の発展。製品、材料、用途、エンドユーザー、地域別に、有利な新興市場に関する包括的な情報を提供します。
市場の多様化。消化管ステント市場における製品ポートフォリオ、成長地域、最近の開発、投資に関する詳細な情報
競合の評価。胃腸用ステント市場における主要企業の市場シェア、成長戦略、製品提供、能力に関する詳細な評価

ページTOPに戻る

Table of Contents

Summary

The gastrointestinal stent market is expected to reach USD 600 million by 2026 from USD 457 million in 2021, at a CAGR of 5.6 % during the forecast period of 2021 to 2026.
Gastrointestinal (GI) stents are designed for palliative therapy for various diseases causing obstruction in the GI tract. GI stents have a major role in the recanalization of gastrointestinal (GI) tumors and postoperative leak sealing. Other potential applications of GI stents are drug-eluting devices, tissue modeling for benign conditions, and GI tract drainage/anastomosis. Gastrointestinal stent market growth can be attributed to the rising prevalence of GI cancers and other digestive diseases, and changing lifestyles, increasing healthcare expenditure on gastrointestinal procedures, and increasing preference for minimally invasive surgeries.

“Biliary stent was the largest product segment and esophageal stent is the fastest-growing gastrointestinal stent segment in market in 2020”
The biliary stents segment accounted for the largest share in 2020. The Esophageal Stents segment is estimated to grow at the highest CAGR during the forecast period. The increasing prevalence of bile duct cancer and chronic liver disease is one of the prominent factors responsible for the growth of the biliary stents segment. Moreover, The increasing incidence of biliary diseases and the growth in the number of surgical procedures for the treatment of biliary diseases are the other major factors that are expected to support the growth of this market segment during the forecast period. According to the American Cancer Society’s statistics, more than 42,230 new cases of intrahepatic bile duct cancer and primary liver cancer are likely to be diagnosed in the US in 2021. Such factors, alongside a serious concern of gastrointestinal disorders such as gallstones in the US, could also contribute to the bile duct stent placement to treat biliary obstruction.
“The self-expanding metal stent segment will dominate the gastrointestinal stent market”
In 2020, the self-expanding metal stent segment accounted for the largest share in the global gastrointestinal stent market. The increased demand for these stents can be attributed to their ease of insertion, a lower possibility of dislodgment or migration, longer patency because of the large luminal diameters, higher longevity, and larger use of it in interventional endoscopy for various malignant obstructions. Self-expanding metal stents are further sub-segmented into nitinol, stainless steel, and other metal stents.
“The Gastrointestinal Cancers segment to register the fastest growth in the global gastrointestinal stent market”
Based on application, the gastrointestinal stent market is segmented into biliary diseases, irritable bowel syndrome, and gastrointestinal cancers. The gastrointestinal cancers segment is further categorized into colorectal cancer, stomach cancer, esophageal cancer, and pancreatic cancer. The biliary diseases segment accounted for the largest share in 2020. The gastrointestinal cancers segment is projected to have the highest CAGR during the forecast period. The growth of this segment is attributed to the increased prevalence and incidences of gastrointestinal cancers. For instance, According to a report by the American Cancer Society, Colorectal Cancer Facts & Figures 2020-2022, in 2020, there were an estimated 104,610 new cases of colon cancer and 43,340 cases of rectal cancer diagnosed in the US.

“Hospitals and clinics is the largest end user segment in the gastrointestinal stent market in 2020”
Based on end users, the gastrointestinal stent market is segmented into hospitals and clinics and ambulatory surgical centers. The hospitals and clinics segment accounted for the largest share of in 2020. The large share of this segment can be attributed to the large number of endoscopic retrograde cholangio-pancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures performed in hospitals for different disease indications, favorable reimbursement scenarios, and increased government initiatives to provide quality treatment for gastrointestinal diseases.
“North America will continue to dominate the gastrointestinal stent market in 2026”
The gastrointestinal stent market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latina America, and the Middle East and Africa. In 2020, North America accounted for the largest share. The large share of North America in the global market is attributed to the rising geriatric population, high incidence of gastrointestinal diseases, favourable reimbursement scenario, and presence of key market players. Some of the major players in this market are Boston Scientific Corporation (US), C.R. Bard (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cook Medical (US), Cantel Medical (US), and Hobbs Medical (US).

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 20%, Director-level: 60%, and Others: 20%
• By Region - North America: 35%, Europe: 30%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%

Research Coverage:
The report analyzes the gastrointestinal stent market and aims at estimating the market size and future growth potential of various market segments, based on products, material, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the gastrointestinal stent market. The report analyzes this market by product, material, application, end user, and region
 Market Development: Comprehensive information on the lucrative emerging markets, by products, material, application, end user, and region
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the gastrointestinal stent market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the gastrointestinal stent market

ページTOPに戻る

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30

1.2 MARKET DEFINITION 30

1.2.1 INCLUSIONS & EXCLUSIONS 30

1.3 MARKET SCOPE 31

1.3.1 MARKETS COVERED 31

FIGURE 1 GASTROINTESTINAL STENT MARKET 31

1.3.2 YEARS CONSIDERED FOR STUDY 31

1.4 CURRENCY 32

TABLE 1 STANDARD CURRENCY CONVERSION RATES 32

1.5 LIMITATIONS 33

1.6 STAKEHOLDERS 33

1.7 SUMMARY OF CHANGES 34

2 RESEARCH METHODOLOGY 35

2.1 RESEARCH APPROACH 35

FIGURE 2 GASTROINTESTINAL STENT MARKET: RESEARCH METHODOLOGY STEPS 35

FIGURE 3 RESEARCH DESIGN 36

2.1.1 SECONDARY DATA 36

2.1.1.1 Key data from secondary sources 37

2.1.2 PRIMARY DATA 38

FIGURE 4 PRIMARY SOURCES 39

2.1.2.1 Key data from primary sources 40

2.1.2.2 Key industry insights 40

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS (GASTROINTESTINAL STENT MARKET) 41

FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41

2.2 MARKET SIZE ESTIMATION 41

FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42

FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION 42

FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: GASTROINTESTINAL STENT MARKET (2020) 43

FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 44

FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR GASTROINTESTINAL STENT MARKET (2021–2026) 44

FIGURE 12 TOP-DOWN APPROACH 45

2.3 MARKET BREAKDOWN & DATA TRIANGULATION 46

FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 46

2.4 ASSUMPTIONS FOR THE STUDY 47

2.5 LIMITATIONS 47

2.5.1 METHODOLOGY-RELATED LIMITATIONS 47

2.6 RISK ASSESSMENT 48

2.7 ASSESSMENT OF IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET 48

3 EXECUTIVE SUMMARY 49

FIGURE 14 GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2021 VS. 2026 (USD MILLION) 49

FIGURE 15 GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2021 VS. 2026 (USD MILLION) 50

FIGURE 16 GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2021 VS. 2026 (USD MILLION) 51

FIGURE 17 GASTROINTESTINAL STENT MARKET, BY END USER,

2021 VS. 2026 (USD MILLION) 51

FIGURE 18 GEOGRAPHIC SNAPSHOT OF GASTROINTESTINAL STENT MARKET 52

4 PREMIUM INSIGHTS 53

4.1 GASTROINTESTINAL STENT MARKET OVERVIEW 53

FIGURE 19 RISE IN INCIDENCE OF GASTROINTESTINAL CANCERS, IBD, AND OTHER DIGESTIVE DISEASES DRIVE GASTROINTESTINAL STENT MARKET GROWTH 53

4.2 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT AND COUNTRY 54

FIGURE 20 BILIARY STENT HELD LARGEST SHARE OF NORTH AMERICAN MARKET

IN 2020 54

4.3 GASTROINTESTINAL STENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55

FIGURE 21 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 55

4.4 GASTROINTESTINAL STENT MARKET: REGIONAL MIX 55

FIGURE 22 NORTH AMERICA TO BE LARGEST MARKET FOR GASTROINTESTINAL

STENT THROUGHOUT FORECAST PERIOD 55

5 MARKET OVERVIEW 56

5.1 INTRODUCTION 56

5.2 MARKET DYNAMICS 56

FIGURE 23 GASTROINTESTINAL STENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56

5.2.1 DRIVERS 57

5.2.1.1 Rise in the incidence of gastrointestinal cancers, IBD, and

other digestive diseases 57

TABLE 2 GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020 57

TABLE 3 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020 57

5.2.1.2 Increasing healthcare expenditure on gastrointestinal procedures 58

FIGURE 24 EUROPE: COSTS OF GASTROINTESTINAL CANCERS (USD BILLION), 2018 58

5.2.1.3 Ongoing technological advancements in business space 59

5.2.1.4 Increasing preference for minimally invasive surgeries 59

5.2.2 RESTRAINTS 60

5.2.2.1 Major complications associated with GI stent implementation 60

TABLE 4 FREQUENCY OF MOST COMMON STENT-RELATED COMPLICATIONS IN VARIOUS ANATOMIC SITES 60

5.2.2.2 High cost of the procedure and limited reimbursement in

developing countries 61

5.2.3 OPPORTUNITIES 61

5.2.3.1 Development of biodegradable and drug eluting stents 61

5.2.3.2 Growing healthcare sector in emerging economies 61

5.2.4 CHALLENGES 62

5.2.4.1 Stringent regulatory environment 62

6 INDUSTRY INSIGHT S 63

6.1 TECHNOLOGY ANALYSIS 63

6.1.1 RECENT ADVANCES IN GASTROINTESTINAL STENTING TO OFFER IMPROVED STENT PATENCY AND REDUCED STENT-INDUCED COMPLICATIONS, RESULTING IN IMPROVED QUALITY OF LIFE 63

6.2 PRICING ANALYSIS 64

TABLE 5 PRICES FOR GI STENTS (USD) 64

6.3 VALUE CHAIN ANALYSIS 64

FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE 65

6.4 ECOSYSTEM MAPPING 65

FIGURE 26 GASTROINTESTINAL STENT MARKET: ECOSYSTEM ANALYSIS 66

6.5 SUPPLY CHAIN ANALYSIS 66

FIGURE 27 GASTROINTESTINAL STENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN 67

6.6 PORTER’S FIVE FORCES ANALYSIS 68

TABLE 6 GASTROINTESTINAL STENT MARKET: PORTER’S FIVE FORCES ANALYSIS 68

6.6.1 THREAT OF NEW ENTRANTS 68

6.6.1.1 High capital requirement 68

6.6.1.2 High preference for products from well-established brands 69

6.6.2 THREAT OF SUBSTITUTES 69

6.6.2.1 Substitute therapies for gastrointestinal stents 69

6.6.3 BARGAINING POWER OF SUPPLIERS 69

6.6.3.1 Presence of few raw material suppliers 69

6.6.3.2 Supplier switching cost 69

6.6.4 BARGAINING POWER OF BUYERS 69

6.6.4.1 Few companies offer premium products at global level 69

6.6.5 INTENSITY OF COMPETITIVE RIVALRY 70

6.6.5.1 Increasing demand for high-quality and innovative products 70

6.6.5.2 Lucrative growth potential in emerging markets 70

6.7 REGULATORY ANALYSIS 70

TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING

THE GASTROINTESTINAL STENT MARKET 70

6.7.1 NORTH AMERICA 71

6.7.1.1 US 71

TABLE 8 US FDA: CLASSIFICATION OF MEDICAL DEVICES 71

6.7.1.2 Canada 71

6.7.2 EUROPE 72

6.7.3 ASIA PACIFIC 72

6.7.3.1 India 72

6.7.3.2 China 72

TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION 73

6.7.3.3 Japan 73

TABLE 10 PMDA: CLASSIFICATION OF MEDICAL DEVICES 73

6.8 PATENT ANALYSIS 74

6.8.1 PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS 74

FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN GASTROINTESTINAL STENT MARKET, 2015–2021 74

6.8.2 TOP APPLICANTS (COMPANIES) OF GASTROINTESTINAL STENTS PATENTS 75

FIGURE 29 TOP COMPANIES THAT APPLIED FOR GASTROINTESTINAL STENTS PATENTS, 2018 AND 2021 75

6.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS

IN GASTROINTESTINAL STENT MARKET 75

FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR GASTROINTESTINAL STENT PATENTS, 2015–2021 75

6.9 YC–YCC TRENDS/DISRUPTION IMPACTING CUSTOMER BUSINESS 76

FIGURE 31 YC–YCC SHIFT IN GASTROINTESTINAL STENT MARKET 76

6.10 IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET 77

TABLE 11 IMPACT OF COVID-19 ON SALES OF KEY MARKET PLAYERS 77

7 GASTROINTESTINAL STENT MARKET, BY PRODUCT 78

7.1 INTRODUCTION 79

FIGURE 32 BILIARY SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET

BY 2026 79

TABLE 12 GLOBAL GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 79

TABLE 13 GASTROINTESTINAL STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 80

7.2 BILIARY STENTS 80

7.2.1 INCREASING PREVALENCE OF BILE DUCT CANCER AND CHRONIC

LIVER DISEASE TO DRIVE THE GROWTH OF THIS SEGMENT 80

TABLE 14 BILIARY STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 81

TABLE 15 BILIARY STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81

7.3 COLONIC STENTS 82

7.3.1 RISING DEMAND FOR COLONIC STENTS DUE TO HIGH INCIDENCE OF COLORECTAL CANCER TO DRIVE SEGMENT GROWTH 82

TABLE 16 COLONIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 82

TABLE 17 COLONIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83

7.4 DUODENAL STENTS 83

7.4.1 INCREASING PREVALENCE OF INTESTINAL MALIGNANCY TO ADOPT DUODENAL STENTS 83

TABLE 18 DUODENAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 84

TABLE 19 DUODENAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84

7.5 PANCREATIC STENTS 85

7.5.1 RISING NUMBER OF ERCP AND PTC PROCEDURES TO DRIVE

SEGMENT GROWTH 85

TABLE 20 PANCREATIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 85

TABLE 21 PANCREATIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86

7.6 ESOPHAGEAL STENTS 86

7.6.1 INCREASING INCIDENCE OF ESOPHAGEAL CANCER TO DRIVE ESOPHAGEAL STENTS MARKET 86

TABLE 22 ESOPHAGEAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 87

TABLE 23 ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87

8 GASTROINTESTINAL STENT MARKET, BY MATERIAL 88

8.1 INTRODUCTION 89

FIGURE 33 SELF-EXPANDING METAL STENTS SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET BY 2026 89

TABLE 24 GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 89

8.2 SELF-EXPANDING METAL STENTS 90

8.2.1 INCREASING ADOPTION OF SELF-EXPANDING METAL STENTS IN HOSPITAL SETTINGS TO DRIVE THE SEGMENT 90

TABLE 25 SELF-EXPANDING METAL STENTS: KEY PRODUCTS OFFERED

BY THE PROMINENT PLAYERS 90

TABLE 26 SELF-EXPANDING METAL STENTS MARKET, BY TYPE,

2019–2026 (USD MILLION) 91

TABLE 27 GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,

BY COUNTRY, 2019–2026 (USD MILLION) 91

8.2.2 NITINOL STENTS 92

8.2.2.1 Ease of deployment for nitinol stents to drive segment growth 92

TABLE 28 NITINOL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS 92

TABLE 29 NITINOL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 93

8.2.3 STAINLESS STEEL STENTS 93

8.2.3.1 Excellent mechanical properties and medical efficiency of stainless-steel stents to support segment growth 93

TABLE 30 STAINLESS STEEL STENTS: KEY PRODUCTS OFFERED BY THE

PROMINENT PLAYERS 94

TABLE 31 STAINLESS STEEL STENTS MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 94

8.2.4 OTHER METAL STENTS 95

TABLE 32 OTHER METAL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS 95

TABLE 33 OTHER METAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 95

8.3 PLASTIC STENTS 96

8.3.1 FAVORABLE REIMBURSEMENT POLICIES FOR PLASTIC STENTS AND INCREASED DEMAND FOR SHORT-TERM USE OF STENTS TO DRIVE

SEGMENT GROWTH 96

TABLE 34 PLASTIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 96

TABLE 35 PLASTIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97

9 GASTROINTESTINAL STENT MARKET, BY APPLICATION 98

9.1 INTRODUCTION 99

FIGURE 34 BILIARY DISEASES TO DOMINATE GASTROINTESTINAL STENT MARKET,

BY APPLICATION, IN 2026 99

TABLE 36 GASTROINTESTINAL STENT MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 99

9.2 BILIARY DISEASES 100

9.2.1 INCREASED AGING POPULATION AND PREVALENCE OF GALLSTONES

TO DRIVE GROWTH 100

TABLE 37 BILIARY DISEASES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100

9.3 GASTROINTESTINAL CANCER 101

9.3.1 GASTROINTESTINAL CANCER IS THE LARGEST APPLICATION SEGMENT

FOR GASTROINTESTINAL STENT 101

TABLE 38 GASTROINTESTINAL CANCER STENT MARKET, BY TYPE,

2019–2026 (USD MILLION) 101

TABLE 39 GASTROINTESTINAL CANCER STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 102

9.3.2 COLORECTAL CANCER 103

9.3.2.1 Rise of colorectal cancer cases to drive segment growth 103

TABLE 40 COLORECTAL CANCER STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 103

9.3.3 STOMACH CANCER 104

9.3.3.1 High incidence rate of stomach cancer to drive market share for stomach cancer 104

TABLE 41 STOMACH CANCER STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 104

9.3.4 PANCREATIC CANCER 105

9.3.4.1 Increased prevalence of pancreatic cancer and adoption of stents in endoscopic procedures to drive segment growth 105

TABLE 42 PANCREATIC CANCER STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 105

9.3.5 ESOPHAGEAL CANCER 106

9.3.5.1 Increasing number of esophageal cancer to increase adoption

of esophageal stents 106

TABLE 43 ESOPHAGEAL CANCER STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 106

9.4 IRRITABLE BOWEL SYNDROME 107

9.4.1 INCREASED PREVALENCE OF IRRITABLE BOWEL SYNDROME TO DRIVE DEMAND FOR GI STENTS 107

TABLE 44 IRRITABLE BOWEL SYNDROME STENT MARKET, BY COUNTRY/REGION, 2019–2026 (USD MILLION) 107

10 GASTROINTESTINAL STENT MARKET, BY END USER 108

10.1 INTRODUCTION 109

FIGURE 35 HOSPITALS & CLINICS SEGMENT TO DOMINATE GASTROINTESTINAL

STENT MARKET BY 2026 109

TABLE 45 GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 109

10.2 HOSPITALS & CLINICS 110

10.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL STENTS IN HOSPITALS & CLINICS 110

TABLE 46 REIMBURSEMENT IN HOSPITAL OUTPATIENTS FOR ERCP STENTING PROCEDURES (USD) 111

TABLE 47 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111

10.3 AMBULATORY SURGICAL CENTERS 112

10.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE AMBULATORY SURGICAL CENTERS 112

TABLE 48 US: NUMBER OF ASCS, (2013–2018) 112

TABLE 49 REIMBURSEMENT IN ASC FOR ERCP STENTING PROCEDURES (USD) 113

TABLE 50 AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 113

11 GASTROINTESTINAL STENT MARKET, BY REGION 114

11.1 INTRODUCTION 115

FIGURE 36 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL SEGMENT DURING FORECAST PERIOD 115

TABLE 51 GASTROINTESTINAL STENT MARKET, BY REGION, 2019–2026 (USD MILLION) 116

11.2 NORTH AMERICA 116

TABLE 52 NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND 5 YEAR PREVALENCE ( 2020) 116

FIGURE 37 NORTH AMERICA: GASTROINTESTINAL STENT MARKET SNAPSHOT 117

TABLE 53 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 117

TABLE 54 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 118

TABLE 55 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 118

TABLE 56 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 118

TABLE 57 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 119

TABLE 58 NORTH AMERICA: GASTROINTESTINAL CANCER STENTS MARKET,

BY GASTROINTESTINAL CANCERS, 2019–2026 (USD MILLION) 119

TABLE 59 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 119

11.2.1 US 120

11.2.1.1 US to dominate North America gastrointestinal stent market

during forecast period 120

TABLE 60 US: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER

BY GASTROINTESTINAL CANCER (2020) 120

TABLE 61 US: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 121

TABLE 62 US: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 121

TABLE 63 US: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,

BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 121

TABLE 64 US: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 122

TABLE 65 US: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 122

TABLE 66 US: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 122

11.2.2 CANADA 123

11.2.2.1 Growing geriatric population and increased incidence of gastrointestinal disorders to drive gastrointestinal stents demand 123

TABLE 67 CANADA: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER,

BY GASTROINTESTINAL CANCER (2020) 123

TABLE 68 CANADA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 123

TABLE 69 CANADA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 124

TABLE 70 CANADA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,

BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 124

TABLE 71 CANADA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 124

TABLE 72 CANADA: GASTROINTESTINAL CANCER STENTS MARKET,

BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 125

TABLE 73 CANADA: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 125

11.3 EUROPE 125

TABLE 74 EUROPE: GASTROINTESTINAL CANCER INCIDENCE, BY GASTROINTESTINAL CANCER (2020) 125

FIGURE 38 EUROPE: GASTROINTESTINAL STENT MARKET SNAPSHOT 126

TABLE 75 EUROPE: GASTROINTESTINAL STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 127

TABLE 76 EUROPE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 127

TABLE 77 EUROPE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 127

TABLE 78 EUROPE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 128

TABLE 79 EUROPE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 128

TABLE 80 EUROPE: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 128

TABLE 81 EUROPE: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 129

11.3.1 GERMANY 129

11.3.1.1 Germany dominated the European gastrointestinal stent

market in 2020 129

TABLE 82 GERMANY: GI CANCER INCIDENCE, IN 2020 129

TABLE 83 GERMANY: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 130

TABLE 84 GERMANY: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 130

TABLE 85 GERMANY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 130

TABLE 86 GERMANY: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 131

TABLE 87 GERMANY: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 131

TABLE 88 GERMANY: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 131

11.3.2 FRANCE 132

11.3.2.1 Favorable statutory health insurance system to boost gastrointestinal stents adoption 132

TABLE 89 FRANCE: GI CANCER INCIDENCE, (2020) 132

TABLE 90 FRANCE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 132

TABLE 91 FRANCE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 133

TABLE 92 FRANCE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 133

TABLE 93 FRANCE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 133

TABLE 94 FRANCE: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 134

TABLE 95 FRANCE: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 134

11.3.3 UK 134

11.3.3.1 Increased incidence of gastrointestinal cancers and minimally invasive surgeries to increase gastrointestinal stents adoption 134

TABLE 96 UK: GASTROINTESTINAL CANCER INCIDENCE (2020) 135

TABLE 97 UK: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 135

TABLE 98 UK: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 136

TABLE 99 UK: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL,

2019–2026 (USD MILLION) 136

TABLE 100 UK: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 136

TABLE 101 UK: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 137

TABLE 102 UK: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 137

11.3.4 ITALY 137

11.3.4.1 Aging population and initiatives to build awareness about digestive health to increase gastrointestinal stent adoption 137

TABLE 103 ITALY: GASTROINTESTINAL CANCER INCIDENCE (2020) 138

TABLE 104 ITALY: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 138

TABLE 105 ITALY: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 139

TABLE 106 ITALY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 139

TABLE 107 ITALY: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 139

TABLE 108 ITALY: GASTROINTESTINAL CANCER STENT MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 140

TABLE 109 ITALY: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 140

11.3.5 SPAIN 140

11.3.5.1 Increased prevalence of gastrointestinal diseases to raise demand for gastrointestinal stent 140

TABLE 110 SPAIN: GASTROINTESTINAL CANCER INCIDENCE (2020) 140

TABLE 111 SPAIN: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 141

TABLE 112 SPAIN: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 141

TABLE 113 SPAIN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 142

TABLE 114 SPAIN: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 142

TABLE 115 SPAIN: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 142

TABLE 116 SPAIN: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 143

11.3.6 REST OF EUROPE 143

TABLE 117 ROE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 144

TABLE 118 ROE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 144

TABLE 119 ROE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,

BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 144

TABLE 120 ROE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 145

TABLE 121 ROE: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 145

TABLE 122 ROE: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 145

11.4 ASIA PACIFIC 146

TABLE 123 ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE (2020) 146

FIGURE 39 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET SNAPSHOT 147

TABLE 124 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY COUNTRY,

2019–2026 (USD MILLION) 147

TABLE 125 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 148

TABLE 126 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 148

TABLE 127 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 148

TABLE 128 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 149

TABLE 129 ASIA PACIFIC: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 149

TABLE 130 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 149

11.4.1 CHINA 150

11.4.1.1 Increasing healthcare expenditure and government initiatives to modernize healthcare system and support market growth 150

TABLE 131 CHINA: GASTROINTESTINAL CANCER INCIDENCE, (2020) 150

TABLE 132 CHINA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 151

TABLE 133 CHINA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 151

TABLE 134 CHINA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 151

TABLE 135 CHINA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 152

TABLE 136 CHINA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 152

TABLE 137 CHINA: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 152

11.4.2 JAPAN 153

11.4.2.1 Strong healthcare system and increased geriatric population

to drive market growth 153

TABLE 138 JAPAN: GASTROINTESTINAL CANCER INCIDENCE (2020) 153

TABLE 139 JAPAN: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 154

TABLE 140 JAPAN: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 154

TABLE 141 JAPAN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 154

TABLE 142 JAPAN: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 155

TABLE 143 JAPAN: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 155

TABLE 144 JAPAN: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 155

11.4.3 INDIA 156

11.4.3.1 Increasing prevalence of gastrointestinal disorders and presence of global and local market players to drive market growth 156

TABLE 145 INDIA: GASTROINTESTINAL CANCER INCIDENCE (2020) 156

TABLE 146 INDIA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 156

TABLE 147 INDIA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 157

TABLE 148 INDIA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 157

TABLE 149 INDIA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 157

TABLE 150 INDIA: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 158

TABLE 151 INDIA: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 158

11.4.4 REST OF ASIA PACIFIC 158

TABLE 152 ROAPAC: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 159

TABLE 153 ROAPAC: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 159

TABLE 154 ROAPAC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 159

TABLE 155 ROAPAC: GASTROINTESTINAL STENT MARKET, BY APPLICATION,

2019–2026 (USD MILLION) 160

TABLE 156 ROAPAC: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 160

TABLE 157 ROAPAC: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 160

11.5 LATIN AMERICA 161

11.5.1 INCREASING DISPOSABLE INCOME AND BURDEN OF GASTRIC

CANCER TO DRIVE MARKET GROWTH 161

TABLE 158 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, 2020 161

TABLE 159 BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, 2020 161

TABLE 160 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,

2019–2026 (USD MILLION) 162

TABLE 161 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,

2019–2026 (USD MILLION) 162

TABLE 162 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 162

TABLE 163 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 163

TABLE 164 LATIN AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 163

TABLE 165 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER,

2019–2026 (USD MILLION) 163

11.6 MIDDLE EAST & AFRICA 164

11.6.1 MIDDLE EAST & AFRICA IS THE SMALLEST MARKET FOR GASTROINTESTINAL STENT PRODUCTS 164

TABLE 166 MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020) 164

TABLE 167 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 164

TABLE 168 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 165

TABLE 169 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 165

TABLE 170 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,

BY APPLICATION, 2019–2026 (USD MILLION) 165

TABLE 171 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,

BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 166

TABLE 172 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,

BY END USER, 2019–2026 (USD MILLION) 166

12 COMPETITIVE LANDSCAPE 167

12.1 OVERVIEW 167

12.2 KEY PLAYER STRATEGIES 167

12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 168

12.4 KEY PLAYERS RANKING (2020) 168

FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 168

12.5 COMPETITIVE BENCHMARKING 170

12.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS 170

12.5.2 PRODUCT AND REGIONAL FOOTPRINT OF COMPANIES

IN GASTROINTESTINAL STENT MARKET 171

TABLE 173 PRODUCT TYPE FOOTPRINT OF COMPANIES (20 MARKET PLAYERS) 172

TABLE 174 MATERIAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS) 173

TABLE 175 REGIONAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS) 174

12.6 COMPETITIVE LEADERSHIP MAPPING 175

12.6.1 STARS 175

12.6.2 EMERGING LEADERS 175

12.6.3 PERVASIVE PLAYERS 175

12.6.4 PARTICIPANTS 176

FIGURE 42 GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP

MAPPING (2020) 176

12.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 177

12.7.1 PROGRESSIVE COMPANIES 177

12.7.2 DYNAMIC COMPANIES 177

12.7.3 STARTING BLOCKS 177

12.7.4 RESPONSIVE COMPANIES 177

FIGURE 43 GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP

MAPPING FOR START-UPS (2020) 178

12.8 COMPETITIVE SCENARIO 178

12.8.1 PRODUCT LAUNCHES & APPROVALS 178

TABLE 176 GASTROINTESTINAL STENT MARKET: KEY PRODUCT LAUNCHES

& APPROVALS, 2018–2021 178

12.8.2 DEALS 179

TABLE 177 GASTROINTESTINAL STENT MARKET: KEY DEALS, 2018–2021 179

13 COMPANY PROFILES 180

13.1 KEY PLAYERS 180

(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats)*

13.1.1 BOSTON SCIENTIFIC CORPORATION 180

TABLE 178 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 180

FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 181

13.1.2 COOK GROUP 183

TABLE 179 COOK GROUP: BUSINESS OVERVIEW 183

13.1.3 TAEWOONG MEDICAL 186

TABLE 180 TAEWOONG MEDICAL: BUSINESS OVERVIEW 186

13.1.4 MICRO-TECH (NANJING) CO., LTD. 188

TABLE 181 MICRO-TECH (NANJING) CO., LTD.: BUSINESS OVERVIEW 188

13.1.5 OLYMPUS CORPORATION 189

TABLE 182 OLYMPUS CORPORATION: BUSINESS OVERVIEW 189

FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 190

13.2 OTHER PLAYERS 192

13.2.1 MERIT MEDICAL SYSTEMS 192

TABLE 183 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 192

FIGURE 46 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 193

13.2.2 BECTON, DICKINSON AND COMPANY 195

TABLE 184 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 195

FIGURE 47 BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT (2020) 196

13.2.3 MEDTRONIC 197

TABLE 185 MEDTRONIC: BUSINESS OVERVIEW 197

FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2020) 198

13.2.4 CANTEL MEDICAL 199

TABLE 186 CANTEL MEDICAL: BUSINESS OVERVIEW 199

FIGURE 49 CANTEL MEDICAL: COMPANY SNAPSHOT (2020) 200

13.2.5 CONMED CORPORATION 202

TABLE 187 CONMED CORPORATION: BUSINESS OVERVIEW 202

FIGURE 50 CONMED CORPORATION: COMPANY SNAPSHOT (2020) 203

13.2.6 ELLA-CS, S.R.O. 204

TABLE 188 ELLA-CS, S.R.O.: BUSINESS OVERVIEW 204

13.2.7 ENDO-FLEX GMBH 206

TABLE 189 ENDO-FLEX GMBH: BUSINESS OVERVIEW 206

13.2.8 MI-TECH 207

TABLE 190 MI-TECH : BUSINESS OVERVIEW 207

13.2.9 HOBBS MEDICAL INC. 209

TABLE 191 HOBBS MEDICAL INC.: BUSINESS OVERVIEW 209

13.2.10 QUALIMED 210

TABLE 192 QUALIMED: BUSINESS OVERVIEW 210

13.2.11 UK MEDICAL 211

TABLE 193 UK MEDICAL: BUSINESS OVERVIEW 211

13.2.12 CITEC 212

TABLE 194 CITEC: BUSINESS OVERVIEW 212

13.2.13 MEDORAH MEDITEK PVT. LTD. 213

TABLE 195 MEDORAH MEDITEK PVT. LTD.: BUSINESS OVERVIEW 213

13.2.14 BCM CORPORATION 214

TABLE 196 BCM CORPORATION: BUSINESS OVERVIEW 214

13.2.15 LEUFEN MEDICAL GMBH 215

TABLE 197 LEUFEN MEDICAL GMBH: BUSINESS OVERVIEW 215

*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX 216

14.1 DISCUSSION GUIDE 216

14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220

14.3 AVAILABLE CUSTOMIZATIONS 222

14.4 RELATED REPORTS 222

14.5 AUTHOR DETAILS 223

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（金属材料）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（金属材料）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?